Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03115463 · ClinicalTrials.gov registry record · NA

Saturation Targets and Resuscitation in Preterm Trial

A NA study of Oxidative Stress, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT03115463: Completed NA study of Oxidative Stress, sponsored by University of Texas Southwestern Medical Center.

NCT03115463 is a NA study of Oxidative Stress that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 75 participants, below the 84-participant average among 36 other Oxidative Stress trials with a reported enrollment target (11% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03115463, a NA study of Oxidative Stress, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research project is to determine if use of optimized target oxygen strategy during delivery room resuscitation can reduce oxidative stress in premature newborns. Objective is to compare oxidative stress markers between preterm neonates resuscitated in the delivery room using three different target oxygen strategies. OX50 target oxygen strategy is currently in use and recommended by neonatal resuscitation program. In this strategy oxygen is adjusted to meet the goal transitional saturations which are approximated 50th centile saturations observed in healthy term newborns. In OX25 target oxygen strategy oxygen will be adjusted to meet the goal transitional saturations which are 25th percentile transitional saturations observed in healthy term newborns. In OX75 target oxygen strategy oxygen will be adjusted to meet the goal transitional saturations which are 75th percentile transitional saturations observed in healthy term newborns.

Primary Outcome

Difference in oxidative balance ratio between Cord blood and postnatal sample obtained within 2 hours of life will be assessed.

Conditions Studied

Interventions

  • OTHER Titration of oxygen during neonatal resuscitation

Study Locations (1)

Texas

  • Parkland Hospital - Dallas

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2017-09-20
Est. Completion 2022-09-30
Phase NA

What the finished NCT03115463 record still lists

NCT03115463 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 84-participant average among 36 other Oxidative Stress trials with a reported enrollment target (11% lower).

The record links to 1 condition, with Oxidative Stress appearing as the primary indexed condition, and to 1 intervention - of which Titration of oxygen during neonatal resuscitation is the first listed.

NCT03115463 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03115463 about?

NCT03115463 is a clinical study titled "Saturation Targets and Resuscitation in Preterm Trial". The purpose of this research project is to determine if use of optimized target oxygen strategy during delivery room resuscitation can reduce oxidative stress in premature newborns. Objective is to compare oxidative stress markers between preterm neonates resuscitated in the delivery room using thre...

What is the current status of trial NCT03115463?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2017-09-20. Estimated completion is 2022-09-30.

What conditions does trial NCT03115463 study?

This clinical trial studies the following conditions: Oxidative Stress.

What interventions are being tested in trial NCT03115463?

The interventions under investigation include: Titration of oxygen during neonatal resuscitation (OTHER).

Who is sponsoring clinical trial NCT03115463?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03115463 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Oxidative Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03115463's enrollment target sits among peer trials

75 11th of 36 higher than 26 of 36 other Oxidative Stress trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Oxidative Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03115463, the US trial registry maintained by the National Library of Medicine. NCT03115463 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.